It is also known as 2,3,4,5-TETRADEHYDRO ALFUZOSIN HYDROCHLORIDE, it is an impurity of Alfuzosin HCl. Alfuzosin is an alpha 1 blocker. Reference standards of Alfuzosin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
2-Chloro-N-(3,4-dimethoxyphenyl)-6,7-dimethoxy-4-quinazolinamine
Catalogue No.:PA 01 37510
CAS :
Molecular Formula : C18H18ClN3O4
Molecular Weight : 375.81
Alfuzosin-d3 Hydrochloride
Catalogue No.:PA STI 004630
Molecular Formula : C19H25D3ClN5O4
Molecular Weight : 428.93
N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-(methyl-d3)-2-cyanoethylamine
Catalogue No.:PA STI 005800
Molecular Formula : C14H14D3N5O2
Molecular Weight : 290.34
N2-Methyl Alfuzosin-d7 Hydrochloride
Catalogue No.:PA STI 060180
Molecular Formula : C19H21D7ClN5O4
Molecular Weight : 432.95
2,3,4,5-Tetradehydro Alfuzosin-d3 Hydrochloride
Catalogue No.:PA STI 081750
Molecular Formula : C19H21D3ClN5O4
Molecular Weight : 424.90
Alfuzosin for system suitability (Y0000832)
Catalogue No.:PA EPY0000832
Molecular Formula : NA
Molecular Weight : NA
alfuzosin impurity standard (847RB)
Catalogue No.:PA BP847RB
Alfuzosin System Suitability Mixture (1012928)
Catalogue No.:PA USP1012928
Alfuzosin for system suitability A (Y0001906)
Catalogue No.:PA EPY0001906
Alfuzosin for peak identification (Y0001883)
Catalogue No.:PA EPY0001883
Alfuzosin Hydrochloride (1012917)
Catalogue No.:PA USP1012917
Catalogue No.:PA IPIPRS 121 13
Molecular Formula :
Alfuzosin System Suitability Mixture A (Alfuzosin Hydrochloride containing Impurity A, Impurity D, (1012871)
Catalogue No.:PA USP1012871
alfuzosin hydrochloride (825RB)
Catalogue No.:PA BP825RB
Alfuzosin hydrochloride (A0325800)
Catalogue No.:PA EPA0325800
3-(Benzyl(methyl)amino)propanenitrile
Catalogue No.:PAI 01 014010
Molecular Formula : C11H14N2
Molecular Weight : 174.24
N1-Benzyl-N1-methylpropane-1,3-diamine
Catalogue No.:PAI 01 014020
Molecular Formula : C11H18N2
Molecular Weight : 178.27
N2-(3-(Benzyl(methyl)amino)propyl)-6,7-dimethoxyquinazoline-2,4-diamine
Catalogue No.:PAI 01 014030
Molecular Formula : C21H27N5O2
Molecular Weight : 381.47
6,7-Dimethoxy-N2-(3-(methylamino)propyl)quinazoline-2,4-diamine
Catalogue No.:PAI 01 014040
Molecular Formula : C14H21N5O2
Molecular Weight : 291.35
Alfuzosin-d3
Catalogue No.:PA STI 088386
Molecular Formula : C19H24D3N5O4
Molecular Weight : 392.47
N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-2-cyanoethylamine
Catalogue No.:PA 01 0371000
Molecular Formula : C14H17N5O2
Molecular Weight : 287.32
Alfuzosin-d7
Catalogue No.:PA STI 088719
Molecular Formula : C19H20D7N5O4
Molecular Weight : 396.5
Alfuzosin System Suitability Mixture A (Alfuzosin Hydrochloride containing Impurity A, Impurity D, and Impurity E)
Catalogue No.:PA 01 0371001
Alfuzosin System Suitability Mixture
Catalogue No.:PA 01 0371002
2,4-Quinazolinediamine, N2,N2′-(imino-di-3,1-propanediyl)bis[6,7-dimethoxy-N2-methyl-
Catalogue No.:PA 01 2441000
Molecular Formula : C28H39N9O4
Molecular Weight : 565.68
Alfuzosin
Catalogue No.:PA 01 2440000
Molecular Formula : C19H27N5O4
Molecular Weight : 389.46
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
